Evaluation of the Canadian Agency for drugs and technologies in health activities 2012-2013 to 2015-2016 / prepared by Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. : H14-493/2017E-PDF
"This evaluation covered the activities of the Canadian Agency for Drugs and Technologies in Health (CADTH) for the period from 2012-2013 to 2015-2016. The evaluation was undertaken in fulfillment of the requirements of the Financial Administration Act and the Treasury Board of Canada’s Policy on Results (2016) ... The purpose of the evaluation was to assess the relevance and performance of CADTH’s activities. The scope of the evaluation covered various CADTH activities from April 2012 to March 2016, including health technology assessments (HTAs), optimal use projects and common drug reviews (CDR). Where warranted, data outside this timeframe was included in the evaluation"--Executive summary, page ii.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.932127&sl=1
| Ministère/Organisme | Canada. Health Canada. Office of Audit and Evaluation, issuing body. Public Health Agency of Canada. Office of Audit and Evaluation, issuing body. |
|---|---|
| Titre | Evaluation of the Canadian Agency for drugs and technologies in health activities 2012-2013 to 2015-2016 / prepared by Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Cover title. Issued also in French under title: Évaluation des activités de l’Agence canadienne des médicaments et des technologies de la santé de 2012-2013 à 2015-2016. Includes bibliographical references (pages 52-54). |
| Information sur la publication | [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, March 2017. |
| Description | 1 online resource (v, 54 pages) : illustrations, graphs |
| Numéro de catalogue |
|
| Descripteurs | Canadian Agency for Drugs and Technologies in Health -- Evaluation. |